Xconomy’s EXOME Presents: Seattle’s Life Science Disruptors 2016

Seattle is one of the few cities in the world with a dense confluence of biotechnology, medicine, information technology, and public health expertise, and a footprint small enough to encourage intense collaboration between the sectors. From that mix come new ideas, products, and organizations that aim to change the way new therapies are created and how people in the U.S. and around the world get their healthcare.

On May 2, we’ll gather at the Fred Hutchinson Cancer Research Center to hear from and talk to some of the most forward-thinking scientists, executives, entrepreneurs, and investors from Seattle and beyond whose work is shaking up entrenched healthcare practices. New drugs. Global initiatives. Better prevention and diagnosis. Deeper analysis. Join us for a healthy dose of thought-provoking conversation.

Speakers Include:
David Baker, Head of the Institute for Protein Design, University of Washington
Aaron Chevalier, CTO, Virvio
Rhea Coler, SVP Preclinical and Translational Research, Infectious Disease Research Institute
Larry Corey, Principal Investigator, HIV Vaccine Trials Network
Jennifer Dent, President, BIO Ventures for Global Health
John Fluke, Chairman, Fluke Capital Management
Stephen Friend, Co-founder, President, & Director, Sage Bionetworks
Rob Hershberg, CSO, Celgene
Leen Kawas, CEO, M3 Biotechnology
Thong Le, CEO, Accelerator
Clayton Lewis, CEO, Arivale
Molly Moore, Assistant Director, Direct Health Solutions Business Development, Cambia Health Solutions
Lucas Nivon, CEO, Cyrus Biotechnology
Ingrid Swanson Pultz, President, PVP Biologics
Nicole Robinson, VP of Industry Relations & Business Development, Fred Hutchinson Cancer Research Center
Andrew Scharenberg, Principal Investigator, Seattle Children’s Research Institute
Jim Thomas, CEO, Just Biotherapeutics
Matthew Trunnell, Chief Information Officer, Fred Hutchinson Cancer Research Center
Cameron Turtle, Immunotherapy researcher and Oncologist, Fred Hutchinson Cancer Research Center
Austin Walsh, Senior State Executive for Washington and Alaska, IBM


Registration & Networking: 12:30 – 1:30 pm
Program: 1:30 – 5:30 pm
Networking Reception: 5:30 – 6:30 pm
Full agenda

Ticket Information:
Procrastinator’s Special: $175.00
Regular Registration: $275.00
Startup Special: $150.00
Student Registration: $40.00
At the Door: $350.00
Tickets are transferable but not refundable.

Fred Hutch
Cooley      Fenwick & West
Seattle Children's
Square1 Bank